Tech Company Inital Public Offerings
Axcella Health IPO
Axcella Health was acquired by . Shares were listed on 5/8/2019.
Transaction Overview
Company Name
Announced On
5/8/2019
Transaction Type
IPO
Amount
$72,000,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds and existing cash on hand as follows: approximately $90.0 million to advance our current liver (AXA1665, AXA1125 and AXA1957) and other programs, including through additional Non-IND, IRB-Approved Clinical Studies, potential IND filing(S) and the ensuing Clinical Trials, including our planned IND filing and Clinical Trial for AXA1665, and infrastructure to support our pipeline; approximately $30.0 million to advance our AXA Development Platform discovery efforts, intellectual property and associated infrastructure; and the remainder, if any, for working capital and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Consumer
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Axcella Health (Nasdaq: AXLA) is a pioneer in developing transformative medicines for patients with diseases in which disrupted amino acid biology plays a central role.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/8/2019: Elligo Health Research venture capital transaction
Next: 5/8/2019: Greyrock Energy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs